A running record of updates, status changes and corrections. The point of dating everything is that you can see what was checked and when.
How this log works
Every material change to Vitrex content is recorded here with the month it was made — new pages, status changes, corrections. If a regulator, WADA or a major trial changes the picture for a substance, the affected page is updated and the change is logged. Corrections requested by readers are logged too.
Menopause pathway, clinic-services page and 17 adjacent-therapy pages
Added the Menopause & perimenopause pathway; the After-the-intake page describing Doctor G Medical's services; and pages for menopausal hormone therapy, hormone pellets, thyroid, botulinum toxin, collagen biostimulators, PDO threads, microneedling/RF, HIFU, cryolipolysis, hair-loss treatments, B12, vitamin D, lipotropic shots, IV vitamin therapy, shockwave, corticosteroid injections and prolotherapy. Approved-vs-research table extended.
Site expansion: pathways, cost, review, safety and 25 new substance pages
Added seven research-pathway pages, the What-it-costs page, How-we-review, Peptide-safety basics, an Approved-vs-research table, the restrictions and lab-work primers, and pages for tesamorelin, TB-500, kisspeptin, thymosin alpha-1, the GLP-1 family, oxytocin, vasopressin, PDA, glutathione, 5-Amino-1MQ, SLU-PP-332 and ten adjacent medicines. All reviewed and dated.
GLP-1 compounding status
Pages for semaglutide and tirzepatide note that the FDA shortage listings ended and compounding of copies is now restricted; FDA warnings about unapproved online products added.
FDA Category 2 placement (historical note)
Recorded on affected pages: BPC-157, CJC-1295, ipamorelin, AOD-9604, injectable GHK-Cu, kisspeptin-10, MOTS-c, thymosin alpha-1 and others placed in Category 2 for compounding.
General education · Not medical advice · Provider approval required
Clinical care Clinical consultations for Vitrex are provided through Doctor G Medical. Treatment decisions are made independently by a licensed provider following medical review.
One short guide to what the research does and does not show, plus new explainers as we publish them. No sales emails, no medical advice, unsubscribe any time.
